Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

EROdicating arterial thrombosis with a novel endoplasmic reticulum oxidoreductase 1α inhibitor

Molecular Therapy(2025)10.1016/j.ymthe.2025.09.012Source: DataRank Database

EROdicating arterial thrombosis with a novel endoplasmic reticulum oxidoreductase 1α inhibitor is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: greenTopics (9)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Anish V. Sharda ORCID,John Hwa ORCID,Timur O. Yarovinsky ORCID

Live enrichment

PubMed:40975058 OpenAlex:https://openalex.org/W4414382172

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U54-DK106857

National Heart Lung and Blood Institute

Grant: R01-HL122815

National Heart Lung and Blood Institute

Grant: R01-HL150515

National Heart Lung and Blood Institute

Grant: K08HL150246

Duke Claude D. Pepper Older Americans Independence Center, Duke Aging Center, Duke University

Grant: P30AG021342

NHLBI NIH HHS

Grant: R01 HL122815

NIDDK NIH HHS

Grant: U54 DK106857

NHLBI NIH HHS

Grant: R01 HL150515

National Institutes of Health

FWCI

0.00

Citation Percentile

0.3%

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12848167/

publisherhttps://api.elsevier.com/content/article/PII:S1525001625007403?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001625007403?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2025.09.012

Fields of Study

Retinal Diseases and TreatmentsEndoplasmic Reticulum Stress and DiseaseAtherosclerosis and Cardiovascular DiseasesMedicine

Keywords

Endoplasmic reticulumOxidoreductaseThrombosisEnzymePathogenesis